2019
DOI: 10.1097/ccm.0000000000003552
|View full text |Cite|
|
Sign up to set email alerts
|

Monoacylglycerol Lipase Inactivation by Using URB602 Mitigates Myocardial Damage in a Rat Model of Cardiac Arrest

Abstract: Objectives: Monoacylglycerol lipase participates in organ protection by regulating the hydrolysis of the endocannabinoid 2-arachidonoylglycerol. This study investigated whether blocking monoacylglycerol lipase protects against postresuscitation myocardial injury and improves survival in a rat model of cardiac arrest and cardiopulmonary resuscitation. Design: Prospective randomized laboratory study. Setting: … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 26 publications
1
3
0
Order By: Relevance
“…Second, due to the severe strike of CA/CPR, hemodynamic instability and severe left ventricular dysfunction that occurred in the early period after ROSC (22, 25), which were also consistent with our study. These alterations may be the leading reasons for the high early mortality after ROSC.…”
Section: Discussionsupporting
confidence: 91%
“…Second, due to the severe strike of CA/CPR, hemodynamic instability and severe left ventricular dysfunction that occurred in the early period after ROSC (22, 25), which were also consistent with our study. These alterations may be the leading reasons for the high early mortality after ROSC.…”
Section: Discussionsupporting
confidence: 91%
“…We established the 5‐min asphyxia CA‐CPR model based on previous method with a slight modification [12]. Each rat was anesthetized with pentobarbital sodium solution (45 mg·kg −1 ).…”
Section: Methodsmentioning
confidence: 99%
“…MAGL inhibition gives promising results in the case of cardiac arrest. Administration of single dose of URB602 (5mg/kg), a MAGL inhibitor, turned out to significantly improve survival rate and reduce myocardial injury in the rodent model [263].…”
Section: Myocardial Dysfunctionsmentioning
confidence: 99%